Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

156.12 +1.66 (+1.07%)
Official Closing Price Updated: 7:00 PM EDT, May 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,974,542
Open 156.07
Bid (Size) 155.95 (1)
Ask (Size) 156.15 (2)
Prev. Close 154.46
Today's Range 155.04 - 156.72
52wk Range 140.68 - 169.99
Shares Outstanding 2,628,679,824
Dividend Yield 3.18%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
Via The Motley Fool
Topics Earnings Economy Government
Exposures Financial Political Supply Chain
Johnson & Johnson - Elliott Wave Technical Analysis
We are tracking a potential major bottom forming in Primary wave 2. A clear five-wave move into wave {i} suggests the early stages of an upside trend resumption. 
Via Talk Markets

Performance

YTD
+8.4%
+8.4%
1 Month
-2.3%
-2.3%
3 Month
+2.8%
+2.8%
6 Month
-1.3%
-1.3%
1 Year
+4.6%
+4.6%

More News

Read More
40-Year-Old Making $4K a Month in Dividends Reveals His Top 8 Stocks — 'We Don't Wear Fancy Clothes or Spend Money on Impressing Others'
Via Benzinga
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?
Via Investor's Business Daily
Topics Animal Testing Economy Government
Exposures Animal Testing Economy Political
Nvidia, Johnson & Johnson, Hyundai, Toyota, SoftBank CEOs To Join Trump At White House As He Touts Investment Surge In First 100 Days: Report
Via Benzinga
Topics Government
Exposures Political
Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference
From Johnson & Johnson
Via Business Wire
Plaintiff Sues Eli Lilly, Johnson & Johnson Over Alleged Breast Cancer Risk Linked To Antipsychotic Medications
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
AbbVie Immunology Portfolio Poised For Growth Through Humira Erosion: Analyst
Via Benzinga
CG Oncology Rockets On Its Johnson & Johnson-Rivaling Cancer Drug
Via Investor's Business Daily
3 Industry Behemoths Are Rewarding Investors With Dividend Bumps
Via MarketBeat
Topics World Trade
Exposures Tariff
3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.
Via MarketBeat
Topics Artificial Intelligence Economy Government
Exposures Artificial Intelligence Economy Political
These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?
Via The Motley Fool
Topics Economy Government Lawsuit
Exposures Financial Interest Rates Legal
3 Dividend Kings That Have Raised Their Payouts in 2025
Via The Motley Fool
Topics Economy
Exposures Interest Rates
In the Wake of the Trump Tariff Crash: 2 Unparalleled Dividend Stocks to Buy at a Discount Right Now
Via The Motley Fool
Topics Economy Government Stocks
Exposures Interest Rates Political Tariff
Merck (MRK) Reports Q1: Everything You Need To Know Ahead Of Earnings
Via StockStory
Bristol-Myers Squibb (BMY) Reports Earnings Tomorrow: What To Expect
Via StockStory
Trump Administration Considers Lowering US Drug Prices To International Levels: Report
Via Benzinga
Topics Government
Exposures Political
JNJ Q1 Earnings: Pipeline Progress and MedTech Execution Drive Guidance Above Expectations
Via StockStory
Topics Earnings World Trade
Exposures Financial Tariff
Why Johnson & Johnson, Chevron, And Flowers Foods Are Winners For Passive Income
Via Benzinga
Roche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs
Via Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Johnson & Johnson (JNJ): Buy, Sell, or Hold Post Q1 Earnings?
Via StockStory
Topics Stocks
Exposures US Equities
2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. Government
Via The Motley Fool
Topics Artificial Intelligence Economy Government
Exposures Artificial Intelligence Economy Political
From $50 A Month To $1M Portfolio — Investor Shares Top 10 Holdings, Says 'Finally Reached $1M!' Thanks To Relentless Discipline
Via Benzinga

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 156.12
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 05/02/25 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 410.39B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 410B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.